An observational study in Drug Hypersensitivity, sponsored by University Hospital, Geneva. Terminated at 1 site in Switzerland. Open to participants aged Up to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-19.
Sponsored by University Hospital, Geneva · Observational
The aim of this study is (1) to assess the incidence of suspected drug allergies in a pediatric hospital and the proportion in which these reactions are confirmed to be allergic; (2) to evaluate the diagnostic values of the different allergy tests available; (3) to investigate the pathophysiology of drug allergies, particularly by investigating the role of viruses, and by performing HLA typing and a gene expression profile both in the acute phase of the reaction and 2 months later.
1,916 studies on the registry are indexed under Hypersensitivity; 265 are open to participants now.
This study's enrollment of 207 is above the median of 115 across 479 observational studies indexed under Hypersensitivity.
Browse Hypersensitivity studies →University Hospital, Geneva is the lead sponsor of 372 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children with suspected drug allergies in a pediatric hospital (including ambulatory departments)
Exclusion Criteria:
Incidence of suspected drug allergies in a pediatric hospital and the proportion in which these reactions are confirmed to be allergic
Time frame: 3 years
Evaluation of the diagnostic values of the different allergy tests available
Sensitivity, specificity, negative and positive predictive value
Time frame: 3 years
Determination of the role of viruses, HLA typing and gene expression profile both in the acute phase of the reaction and 2 months later
Time frame: 3 years
This study is terminated, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Geneva